Targeting protective renin-angiotensin system pathways in pulmonary emphysema: Preclinical evidence for resolving inflammation and restoring lung homeostasis.
Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of morbidity and mortality worldwide and still lacks effective disease-modifying therapies. Current pharmacological treatments primarily alleviate symptoms and reduce exacerbations, but have limited ability to prevent progressive lung destru...